Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Starts Life Sciences Philanthropic Organization

NEW YORK (GenomeWeb News) – Invitrogen is starting a philanthropic foundation that will support endeavors focused on increasing participation in and understanding of life sciences by students, teachers, scientists, and the general public, the company said today.
The company said it has granted $1 million to get the foundation going and will provide further funding in the future.
Invitrogen CEO Greg Lucier said the Invitrogen Foundation will “focus on encouraging more students to embrace a career in the sciences, as well as celebrating the accomplishments of today’s researchers and the improvements their work brings to our lives everyday.” 
In addition to supporting specific programs through grants, the foundation intends to develop other resources including an educational website aimed at providing life sciences information to the public, CFO David Hoffmeister added.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.